Antipsychotics and Substance Use: A Fresh Look at Old Drugs

<p>Could antipsychotic switching impact substance use in schizophrenia?<br /> In this episode, Dr. Jim Phelps explores the impact of antipsychotics on patients with schizophrenia and substance use disorder. He includes insights from national cohorts and clinical cases and delves into the potential effects of changing from risperidone to clozapine.</p> <p>Faculty: Jim Phelps, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC264" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-49-2707?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC264" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: Quick Take Vol. 49</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/associations-between-antipsychotic-use-substance-use-and-relapse-risk-in-patients-with-schizophrenia-real-world-evidence-from-2-national-cohorts-2707-5429?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC264" target="_blank" rel="noopener"><strong>Associations Between Antipsychotic Use, Substance Use, and Relapse Risk in Patients with Schizophrenia: Real-World Evidence From 2 National Cohorts</strong></a></li> </ul>